The world’s first spiral intraocular lens (IOL) is now available to surgeons in Australia and New Zealand.

Following a large-scale multicentre data collection study, Rayner released the RayOne Galaxy and RayOne Galaxy Toric, marking a wider global rollout of its nextgeneration full range of focus IOLs.

Developed with artificial intelligence (AI), RayOne Galaxy’s unique nondiffractive spiral optic delivers a smooth and continuous full range of vision with minimised dysphotopsia and 0% loss of transmitted light.1

Ten leading surgeons from 10 countries conducted a pre-launch clinical evaluation, with over 180 eyes treated with RayOne Galaxy and RayOne Galaxy Toric – collecting postoperative clinical outcomes at one and three months. Interim outcomes showed that RayOne Galaxy and RayOne Galaxy Toric provide a full range of vision, without the wave-like defocus pattern associated with diffractive trifocal IOLs. This included mean corrected and uncorrected visual acuities at all distances of 0.1 logMAR or better, and binocular defocus curve visual acuities of 0.2 logMAR or better across a ~4.0 Drange.1

When assessing halos, the evaluation found less halo and glare compared to published data on diffractive trifocal IOLs. In a pre-clinical study of 30 subjects with healthy eyes, RayOne Galaxy demonstrated a halo size closer to that of an enhanced monofocal IOL than a diffractive trifocal IOL.2

The RayOne Galaxy spiral IOL platform has Therapeutic Goods Administration approval in Australia but is not yet listed on the Medicare Benefits Schedule.

For further information, visit rayner.com/Galaxy.

References
1. Rayner 2025. Data on file.
2. Amon et al. ACMIT study. Presented at ESCRS 2024.